Privigen 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DB26FD4RF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,436
Award facts
- Contract value 100% obligated
- $24,435.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,435.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of PRIVIGEN 10% Vial 200ML. The award, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, carries no set-aside designation, indicating the vendor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was recently awarded on November 13, 2025, with a $499.999 billion ceiling value and performance extending through December 31, 2036.
The PPV-G GEN V program represents a critical component of the Department of Defense's broader $30.3 billion pharmaceutical supply chain strategy, enabling the agency to issue delivery orders for prescription medications, biologics, vaccines, and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's expanded role as a prime vendor contractor under this initiative builds upon its demonstrated performance on numerous prior delivery orders and its established position within the Defense Logistics Agency's Medical Supply Chain division, positioning the firm as a key supplier for recurring pharmaceutical requirements across the federal military medical system. No subcontractors are identified in the award documentation.
Quick answers
Who was awarded contract SPE2DB26FD4RF?
SPE2DB26FD4RF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FD4RF worth?
The government has obligated $24,436 on SPE2DB26FD4RF.
Is contract SPE2DB26FD4RF an order under another contract?
Yes. SPE2DB26FD4RF is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB26FD4RF competed?
The extent of competition for SPE2DB26FD4RF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award